U.S. Funds Surge Following Trump's Re-election Confirmation, While Emerging Markets See Decline

Kim SangJin / 기사승인 : 2024-12-11 01:47:55
  • -
  • +
  • 인쇄

Photo = Yonhap news

 

[Alpha Biz= Reporter Kim Sangjin] According to financial information provider FN Guide, following the confirmation of U.S. President Donald Trump's re-election (from November 6 to December 5), the assets set up in U.S. funds in South Korea surged by 1.32 trillion won, a significant increase. In contrast, funds in other major countries, including Japan (-272 billion won), Vietnam (-409 billion won), India (-411 billion won), China (-2.36 trillion won), and other emerging Asian nations like Malaysia, Indonesia, and Thailand (-58 billion won), all saw a decrease in assets. Notably, this is the first time this year that Indian funds have seen a drop in asset inflows. India fund assets, which had exceeded 4 trillion won in October, fell to 3.83 trillion won by the end of November.

In terms of returns, U.S. funds recorded the highest increase during this period, rising by 7.7%. Japan (5.58%), India (3.31%), emerging Asia (3.19%), and Vietnam (0.54%) followed, while Chinese funds experienced a 0.61% decline, making it the only fund to show negative returns during this time.

On a global scale, funds in emerging markets have experienced a sharp decline. According to Bloomberg, after Trump's re-election confirmation, emerging market equity funds saw an outflow of $7.4 billion (approximately 10.3 trillion won) during the week of November 7-13, marking the largest outflow in over nine years, since August 2015. In contrast, U.S. funds saw an inflow of about $56 billion during the same period, the second-highest amount since 2008.

 

 

 

알파경제 Kim SangJin (letyou@alphabiz.co.kr)

어플

주요기사

Amazon Shares Soar 9% After AI-Driven AWS Growth Pushes Earnings Far Beyond Expectations2025.10.31
China Officially Confirms Xi–Trump Summit to Be Held in Busan on October 302025.10.30
NVIDIA CEO Jensen Huang Hints at “Exciting Announcement” for South Korea During GTC 20252025.10.29
Novartis to Acquire Avidity Biosciences for USD 12 Billion, Strengthening RNA Therapeutics Portfolio2025.10.28
Target to Cut 1,800 Corporate Jobs Amid Prolonged Sales Slump2025.10.24
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사